In vitro evidence for a new therapeutic approach in renal cell carcinoma

PURPOSE: Renal cell carcinoma (RCC) is the most lethal among the common urologic malignancies, comprising 3% of all human neoplasias; approximately 40% of patients eventually die of cancer progression. One third of patients who present with metastatic disease and up to 40% treated for localized dise...

Full description

Bibliographic Details
Main Authors: Carmine Pittoggi, Gianni Martis, Giorgia Mastrangeli, Bruno Mastrangeli, Corrado Spadafora
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia 2008-08-01
Series:International Brazilian Journal of Urology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382008000400012